: Paige R. Mccoy
- Paige R. Mccoy first started conducting FDA inspections in 2023, with the last inspection in 2024. Over that time, Paige R. Mccoy has conducted 9 inspections at 8 companies across 9 sites.
Get Paige Mccoy's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Genzyme Corporation, Framingham | 2024
Out-of-stock
Paige R. Mccoy
Human Drugs Form 483
FDA 483 Equibal Inc, Unionville | 2024
Out-of-stock
Paige R. Mccoy
Human Drugs Form 483
FDA 483 Elementis SRL, Inc., Huguenot | 2024
Out-of-stock
Paige R. Mccoy
Human Drugs Form 483
FDA 483 Genzyme Corporation, Ridgefield | 2024
Out-of-stock
Paige R. Mccoy
Human Drugs Form 483
FDA 483 Freethink Technologies, Inc., Branford | 2024
Out-of-stock
Paige R. Mccoy
Human Drugs Form 483
FDA 483 Spirit Pharmaceuticals, Ronkonkoma | 2023
Out-of-stock
Paige R. Mccoy
Human Drugs Form 483
Co-Investigators (14)
- Sean R. Marcsisin, FDA Investigator
- Pushpa S. Jayasekara, FDA Investigator
- Ifechimere I. Okafor,
- Dana A. Razzano, FDA Investigator
- Annet R. Rajan, FDA Investigator
- Jessica S. Estriplet, FDA Investigator
- Stephenie M. Ortiz, FDA Investigator
- Lori M. Newman, FDA Investigator
- Samir C. Gala, FDA Investigator
- Evan Tong, FDA Investigator
- Christian F. Gomez Lugo,
- Karen A. Briggs, FDA Investigator
- Michael O. Idowu,
- Gam S. Zamil, FDA Investigator